Anti-Müllerian hormone (AMH) and FSH levels can be used to assess the antral follicle count to estimate ovarian reserve, although FSH values may vary in cancer survivors; AMH seems to be well correlated with estimation of ovarian reserve [48]. Here, BRD2 is linked to cancer.